Semin Vasc Med 2005; 05(4): 371-374
DOI: 10.1055/s-2005-922482
Copyright © 2005 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA.

D-Dimer Levels, Constitutional Thrombophilia, and Venous Thrombosis Prediction: Clinical Aspects and Implications

M. M. Samama1 , M. H. Horellou1 , I. Elalamy1 , V. Mathieux2 , E. Ombandza-Moussa1 , J. Conard1
  • 1University Hospital, Hôtel-Dieu, Paris, France
  • 2Clinique Universitaire, Mont Godinne, Belgium
Weitere Informationen


22. November 2005 (online)


The negative predictive value of D-dimers in the diagnosis of a recent venous thromboembolism (VTE) episode is well established. The plasma level of D-dimer is usually increased in hypercoagulable states. The measurement of D-dimer could be of clinical interest in patients with constitutional thrombophilia as there is no close relationship between the clinical expression and the genotype indicating the existence of a hypercoagulable state. Moreover, the predictive value of D-dimer testing in patients with thrombophilia has been questioned. The review of the literature and results of a recent study of our group are presented. Decreased levels of D-dimer are observed in patients receiving an oral anticoagulant treatment versus untreated patients. In contrast, no significant difference was observed between those with and those without thrombophilia among treated or untreated patients. Patients with constitutional thrombophilia are supposed to have an increased risk of postoperative VTE. The review of the existing literature could not confirm this opinion but this could be due to the fact that most patients receive a prophylactic treatment. Thus, there is an indirect evidence of its efficacy in these patients.


  • 1 Perrier A, Roy P M, Aujesky D et al.. Diagnosing pulmonary embolism in outpatients with clinical assessment, D-dimer measurement, venous ultrasound, and helical computed tomography: a multicenter management study.  Am J Med. 2004;  116 291-299
  • 2 Perrier A, Palareti G. D-dimer testing and venous thromboembolism: four view points.  J Thromb Haemost. 2005;  3 382-384
  • 3 Wells P S, Anderson D R, Rodger M et al.. Evaluation of D-dimer in the diagnosis of suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and D-dimer.  Ann Intern Med. 2001;  135 98-107
  • 4 Ombandza-Moussa E, Samama M M, Horellou M H, Elalamy I, Conard J. Potential use of D-dimer measurement in patients treated with oral anticoagulant for a venous thromboembolic episode.  Int Angiol. 2003;  22 364-369
  • 5 Raimondi P, Bongard O, de Moerloose P, Reber G, Waldvogel F, Bounameaux H. D-dimer plasma concentration in various clinical conditions: implications for the use of this test in the diagnostic approach of venous thromboembolism.  Thromb Res. 1993;  69 125-130
  • 6 Ver Elst K, Jochmans K, De Pauw A, De Waele M. Plasma D-dimer concentrations in different clinical conditions.  Acta Clin Belg. 2002;  57 325-330
  • 7 Palareti G, Legnani C, Cosmi B, Guazzaloca G, Pancani C, Coccheri S. Risk of venous thromboembolic recurrence: high negative predictive value of D-dimer performed after oral anticoagulation is stopped.  Thromb Haemost. 2002;  87 7-12
  • 8 Palareti G, Legnani C, Cosmi B et al.. Predictive value of D-dimer test for recurrent venous thromboembolism after anticoagulation withdrawal in subjects with a previous idiopathic event and in carriers of congenital thrombophilia.  Circulation. 2003;  108 313-318
  • 9 Eichinger S, Minar E, Bialonczyk C et al.. D-dimer levels and risk of recurrent venous thromboembolism.  JAMA. 2003;  290 1071-1074
  • 10 De Stefano V, Leone G, Mastrangelo S et al.. Thrombosis during pregnancy and surgery in patients with congenital deficiency of antithrombin III, protein C, protein S.  Thromb Haemost. 1994;  71 799-800
  • 11 The Procare Group . Comparison of thrombotic risk between 85 homozygotes and 481 heterozygotes carriers of the factor V Leiden mutation: retrospective analysis from the Procare study.  Blood Coagul Fibrinolysis. 2000;  11 511-518
  • 12 Lindahl T L, Lundahl T H, Nilsson L, Andersson C A. APC-resistance is a risk factor for postoperative thromboembolism in elective replacement of the hip or the knee. A prospective study.  Thromb Haemost. 1999;  81 18-21
  • 13 Ryan D H, Crowther M A, Ginsberg J S, Francis C W. Relation of factor V Leiden genotype to risk for acute deep venous thrombosis after joint replacement surgery.  Ann Intern Med. 1998;  128 270-276
  • 14 Woolson S T, Zehnder J L, Maloney W J. Factor V Leiden and the risk of proximal venous thrombosis after total hip arthroplasty.  J Arthroplasty. 1998;  13 207-210
  • 15 Donaldson M C, Belkin M, Whittemore A D, Mannick J A, Longtime J A, Dorfman D M. Impact of activated protein C resistance on general vascular surgical patients.  J Vasc Surg. 1997;  25 1054-1060
  • 16 Tengborn L, Berqvist D. Surgery in patients with congenital antithrombin III deficiency.  Acta Chir Scand. 1988;  154 179-183
  • 17 Di Micco P, D'Uva M, Strina I et al.. The role of D-dimer as first marker of thrombophilia in women affected by sterility: implications in pathophysiology and diagnosis of thrombophilia induced sterility.  J Transl Med. 2004;  9 38

M. M Samama

Hotel-Dieu Hospital, 75181 Paris cedex 04, France